Compare BDL & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BDL | COCH |
|---|---|---|
| Founded | 1959 | 1995 |
| Country | United States | United States |
| Employees | N/A | 42 |
| Industry | Restaurants | Blank Checks |
| Sector | Consumer Discretionary | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 62.6M | 59.7M |
| IPO Year | 1995 | N/A |
| Metric | BDL | COCH |
|---|---|---|
| Price | $32.25 | $0.74 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 1.0K | ★ 336.2K |
| Earning Date | 05-18-2026 | 04-30-2026 |
| Dividend Yield | ★ 1.71% | N/A |
| EPS Growth | ★ 49.72 | N/A |
| EPS | ★ 0.43 | N/A |
| Revenue | ★ $205,248,000.00 | N/A |
| Revenue This Year | N/A | $5.81 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $75.00 | ★ N/A |
| Revenue Growth | ★ 8.99 | N/A |
| 52 Week Low | $22.61 | $0.36 |
| 52 Week High | $35.98 | $1.91 |
| Indicator | BDL | COCH |
|---|---|---|
| Relative Strength Index (RSI) | 48.54 | 51.68 |
| Support Level | $29.56 | $0.64 |
| Resistance Level | $33.12 | $0.73 |
| Average True Range (ATR) | 0.63 | 0.08 |
| MACD | -0.24 | -0.01 |
| Stochastic Oscillator | 31.25 | 32.76 |
Flanigan'S Enterprises Inc operates as a chain of small cocktail lounges and packages liquor stores throughout South Florida. The business activity is principally conducted in two segments namely Restaurant and Package liquor store segment. Its Restaurant segment offers alcoholic beverages and full food service, and Package stores consist of retail liquor sales and related items. Its menu consists of a wide variety of options including prime rib, steaks, pasta, entree salads, burgers, a variety of sandwiches, and oversized signature desserts. The company generates maximum revenue from Restaurant segment.
Envoy Medical Inc is a hearing health company focused on providing medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life. The Company has one reportable segment: hearing. The hearing segment derives revenue from the sale of the Esteem FI-AMEI implants and replacement components to Esteem FI-AMEI implants.